{"id":"anaferon","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-28T00:36:10.895Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03707912","phase":"PHASE4","title":"Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections","status":"COMPLETED","sponsor":"Materia Medica Holding","startDate":"2018-10-09","conditions":"Acute Respiratory Viral Infections","enrollment":204},{"nctId":"NCT03301155","phase":"PHASE4","title":"Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI","status":"COMPLETED","sponsor":"Materia Medica Holding","startDate":"2017-10-03","conditions":"Preventive Medicine","enrollment":1036},{"nctId":"NCT02072174","phase":"PHASE4","title":"Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children","status":"COMPLETED","sponsor":"Materia Medica Holding","startDate":"2014-10-08","conditions":"Influenza and Acute Respiratory Viral Infections","enrollment":569},{"nctId":"NCT03162458","phase":"PHASE3","title":"Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections","status":"COMPLETED","sponsor":"Materia Medica Holding","startDate":"2015-01-22","conditions":"Acute Upper Respiratory Infections","enrollment":142}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":25,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Anaferon","genericName":"Anaferon","companyName":"Materia Medica Holding","companyId":"materia-medica-holding","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":1},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}